These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9004880)

  • 21. [Outcome of combined trabeculectomy with cataract operation and intraocular lens implantation].
    Anton L; Martin H
    Klin Monbl Augenheilkd; 1998 May; 212(5):275-7. PubMed ID: 9677552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laser flare in combined cataract and glaucoma surgery].
    Hille K; Hans J; Manderscheid T; Spang S; Ruprecht KW
    Ophthalmologe; 2001 Jan; 98(1):47-53. PubMed ID: 11220271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery.
    Wedrich A; Menapace R; Ries E; Polzer I
    J Cataract Refract Surg; 1997; 23(6):873-7. PubMed ID: 9292671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic and prophylactic application of TPA (recombinant tissue plasminogen activator) into the anterior chamber of the eye].
    Rehfeldt K; Höh H
    Ophthalmologe; 1999 Sep; 96(9):587-93. PubMed ID: 10501987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic application of tissue plasminogen activator for fibrin reaction after cataract surgery.
    Ozveren F; Eltutar K
    J Cataract Refract Surg; 2004 Aug; 30(8):1727-31. PubMed ID: 15313298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined phacoemulsification, intraocular lens implantation, and trabeculectomy.
    Mamalis N; Lohner S; Rand AN; Crandall AS
    J Cataract Refract Surg; 1996 May; 22(4):467-73. PubMed ID: 8733852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intraocular pressure regulation after combined glaucoma and cataract operation].
    Dittmer K; Quentin CD
    Ophthalmologe; 1998 Jul; 95(7):499-503. PubMed ID: 9738382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk factors, prevention and therapy of fibrin reactions after IOL implantation].
    Müller-Jensen K; Zimmermann H
    Klin Monbl Augenheilkd; 1995 Nov; 207(5):287-91. PubMed ID: 8587303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose tissue plasminogen activator in the management of anterior chamber fibrin formation.
    Georgiadis N; Boboridis K; Halvatzis N; Ziakas N; Moschou V
    J Cataract Refract Surg; 2003 Apr; 29(4):729-32. PubMed ID: 12686240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
    Erol N; Ozer A; Topbas S; Yildirim N; Yurdakul S
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):451-6. PubMed ID: 14620747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of intraocular fibrin formation with tissue plasminogen activator after vitrectomy].
    Zhao P; Wang W
    Zhonghua Yan Ke Za Zhi; 1995 Jul; 31(4):255-8. PubMed ID: 8745515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodialysis catheter-associated fibrin sheaths: treatment with a low-dose rt-PA infusion.
    Savader SJ; Haikal LC; Ehrman KO; Porter DJ; Oteham AC
    J Vasc Interv Radiol; 2000 Oct; 11(9):1131-6. PubMed ID: 11041468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of recombinant tissue plasminogen activator in severe post-operative fibrinous reaction after uneventful phacoemulsification - a case series and review.
    Ibramsah AB; Cheong AI; Wan Muda WN; Ibrahim M
    Rom J Ophthalmol; 2022; 66(1):27-31. PubMed ID: 35531461
    [No Abstract]   [Full Text] [Related]  

  • 35. [The intravitreal application of the tissue plasminogen activator in the treatment of submacular hemorrhage--a case report].
    Fric E; Sín M; Rehák M; Chrapek O; Simicák J; Fehák J
    Cesk Slov Oftalmol; 2008 Nov; 64(6):237-40. PubMed ID: 19110965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
    Szabo S; Letsch R; Ehlers R; Walter T; Kazmaier S; Helber U; Hoffmeister HM
    Thromb Res; 2002 Apr; 106(2):113-9. PubMed ID: 12182909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Report of tissue plasminogen activator (tPA) injection in a very low dose for the treatment of posttrabeculectomy fibrin.
    Burnstein Y; Higginbotham EJ
    J Glaucoma; 1998 Oct; 7(5):361. PubMed ID: 9786567
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment with tissue plasminogen activator (tPA) in risk patients with fibrin reactions after cataract operations].
    Heiligenhaus A; Schilling H; Schilling M; Mellin KB
    Ophthalmologe; 1996 Feb; 93(1):49-53. PubMed ID: 8867161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for unsatisfactory intraocular pressure control in combined trabeculectomy and cataract surgery.
    Yamagami S; Hamada N; Araie M; Shirato S
    Ophthalmic Surg Lasers; 1997 Jun; 28(6):476-82. PubMed ID: 9189951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal corneal phacoemulsification combined with superior trabeculectomy: a controlled study.
    Caprioli J; Park HJ; Weitzman M
    Trans Am Ophthalmol Soc; 1996; 94():451-63; discussion 463-8. PubMed ID: 8981709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.